Explore

Trendline Trendline
Personalis to Engage with Investors at Upcoming Conferences to Highlight Genomic Innovations

Personalis to Engage with Investors at Upcoming Conferences to Highlight Genomic Innovations

Personalis to Engage with Investors at Upcoming Conferences to Highlight Genomic Innovations
Trendline Trendline
Personalis to Engage with Investors at Upcoming Conferences

Personalis to Engage with Investors at Upcoming Conferences

Personalis to Engage with Investors at Upcoming Conferences
Trendline Trendline
Personalis to Engage in Key Investor Conferences to Highlight Precision Oncology Advances

Personalis to Engage in Key Investor Conferences to Highlight Precision Oncology Advances

Personalis to Engage in Key Investor Conferences to Highlight Precision Oncology Advances
Trendline Trendline
Sarepta Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference

Sarepta Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference

Sarepta Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference
Trendline Trendline
Extel Announces 2026 Asia Corporate Results Highlighting Investor Engagement Trends

Extel Announces 2026 Asia Corporate Results Highlighting Investor Engagement Trends

Extel Announces 2026 Asia Corporate Results Highlighting Investor Engagement Trends
Trendline Trendline
Arna Pharma and Slate Run Pharmaceuticals Launch Joint Venture and First Product

Arna Pharma and Slate Run Pharmaceuticals Launch Joint Venture and First Product

Arna Pharma and Slate Run Pharmaceuticals Launch Joint Venture and First Product
Trendline Trendline
Perspective Therapeutics Advances VMT-α-NET with High Response Rates and Manufacturing Expansion

Perspective Therapeutics Advances VMT-α-NET with High Response Rates and Manufacturing Expansion

Perspective Therapeutics Advances VMT-α-NET with High Response Rates and Manufacturing Expansion
Trendline Trendline
Men in Their 40s Turn to Peptide Therapy Amidst Health Concerns

Men in Their 40s Turn to Peptide Therapy Amidst Health Concerns

Men in Their 40s Turn to Peptide Therapy Amidst Health Concerns
Trendline Trendline
Agilent Technologies to Present at Jefferies Global Healthcare Conference 2026

Agilent Technologies to Present at Jefferies Global Healthcare Conference 2026

Agilent Technologies to Present at Jefferies Global Healthcare Conference 2026
Trendline Trendline
FORE Biotherapeutics to Engage in Key Investor Conferences, Highlighting Oncology Innovations

FORE Biotherapeutics to Engage in Key Investor Conferences, Highlighting Oncology Innovations

FORE Biotherapeutics to Engage in Key Investor Conferences, Highlighting Oncology Innovations
Trendline Trendline
Alto Neuroscience to Participate in Major Investor Conferences

Alto Neuroscience to Participate in Major Investor Conferences

Alto Neuroscience to Participate in Major Investor Conferences
Trendline Trendline
BridgeBio's Attruby Shows Potential Superiority Over Pfizer's Tafamidis in ATTR-CM Survival Rates

BridgeBio's Attruby Shows Potential Superiority Over Pfizer's Tafamidis in ATTR-CM Survival Rates

BridgeBio's Attruby Shows Potential Superiority Over Pfizer's Tafamidis in ATTR-CM Survival Rates